The cardiotonic agent amrinone has been postulated to directly affect Na-Ca exchange. Because stimulated bone resorption has been proposed to require Na-Ca exchange, we examined the effects of amrinone on bone. Amrinone inhibited release of Ca from neonatal mouse calvaria in organ culture stimulated by parathyroid hormone (PTH), 1,25-dihydroxyvitamin D3, or prostaglandin E2. Inhibition was dose dependent and maximal at 2 X 10-4 M. The effect of amrinone differed from the inhibitory effects of calcitonin, ouabain, or nigericin in that 6-h exposure to amrinone alone prevented the effect of subsequently added PTH; amrinone was only partially effective if added after resorption was initiated by 24-h treatment with PTH; coincubation with amrinone and PTH during the first 48 h of culture allowed for a response to PTH after amrinone was removed; no such protection by a stimulator occurred with ouabain or nigericin. Also submaximal concentrations of amrinone plus calcitonin, ouabain, or nigericin gave greater than additive inhibition of Ca release. Amrinone had no effect on basal bone cAMP or on the acute stimulation of cAMP by PTH. The results suggest that amrinone could have a more direct interaction with the pathway involved in stimulated bone resorption than the other inhibitors.
|Original language||English (US)|
|Journal||American Journal of Physiology - Endocrinology and Metabolism|
|State||Published - Jan 1 1982|
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Physiology (medical)